AIM
CLB icon

Achmea Investment Management’s Core Laboratories CLB Stock Holding History

Achmea Investment Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-2,121
Closed -$214K – 494
2017
Q2 		$214K Hold
2,121
– – 0.01% 495
2017
Q1 		$245K Buy
+2,121
New +$247K 0.01% 496

Other funds holding CLB

ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
WP
Wedgewood Partners St Louis, Missouri $484M AUM 16.04% 1-Year Est. Return

Achmea Investment Management's CLB Position: Q3 2017 in Review

Achmea Investment Management sold out of Core Laboratories (CLB) in Q3 2017, closing a stake of 2,121 shares — an estimated $214K sold.

Achmea Investment Management first reported a position in CLB in Q1 2017 and held it in 2 quarters. The position peaked at $245K in Q1 2017. 345 funds tracked by Wall St. Rank hold CLB as of Q3 2017.

  • Achmea Investment Management reported no remaining Core Laboratories position as of Q3 2017 after selling out during the quarter.
  • Achmea Investment Management sold 2,121 Core Laboratories shares in Q3 2017, an estimated $214K.
  • Achmea Investment Management first reported a position in Core Laboratories in Q1 2017 and held it in 2 quarters.
  • Achmea Investment Management's Core Laboratories position peaked at $245K in Q1 2017.
  • 345 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2017.

Based on Achmea Investment Management's 13F filing for Q3 2017, filed 9 Nov 2017.